Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (RCEL) Other Operating Expenses (2018 - 2025)

AVITA Medical filings provide 8 years of Other Operating Expenses readings, the most recent being $11.9 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 15.39% to $11.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $53.1 million, a 8.69% decrease, with the full-year FY2025 number at $53.1 million, down 8.69% from a year prior.
  • Other Operating Expenses hit $11.9 million in Q4 2025 for AVITA Medical, down from $12.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $16.3 million in Q2 2024 to a low of $59000.0 in Q4 2023.
  • Median Other Operating Expenses over the past 5 years was $965000.0 (2022), compared with a mean of $6.5 million.
  • Biggest five-year swings in Other Operating Expenses: tumbled 94.25% in 2023 and later soared 23813.56% in 2024.
  • AVITA Medical's Other Operating Expenses stood at $374000.0 in 2021, then soared by 174.33% to $1.0 million in 2022, then tumbled by 94.25% to $59000.0 in 2023, then soared by 23813.56% to $14.1 million in 2024, then dropped by 15.39% to $11.9 million in 2025.
  • The last three reported values for Other Operating Expenses were $11.9 million (Q4 2025), $12.1 million (Q3 2025), and $14.3 million (Q2 2025) per Business Quant data.